Table VI.
Outcomes, Stratified by the Development of POAF among Patients without Pre-existing Atrial Fibrillation*
Outcomes | POAF (N=3602) | No POAF (N=339003) | Unadjusted OR [95% CI] | P value | Adjusted OR [95% CI] | P value |
---|---|---|---|---|---|---|
Mortality | 570 (15.8%) | 6646 (2.0%) | 9.40 [8.57–10.31] | <0.001 | 1.68 [1.52–1.86] | <0.001 |
Readmission 30 days | 529 (14.7%) | 32338 (9.5%) | 1.63 [1.49–1.79] | <0.001 | 1.02 [0.92–1.14] | 0.673 |
Unadjusted Difference in Means [95% CI] | Adjusted Difference in Means [95% CI] | |||||
Length of Stay, median, [IQR]† | 13 [8–22] | 4 [3–7] | +275% [268%–182%] | <0.001 | + 37.3% [33.9%–40.9%] | <0.001 |
Hospitalization Cost, median, [IQR]‡ | 25205 [18041–36280] | +14525 [10202–20987] | +10617 [10224–11011] | <0.001 | + 5914 [5416–6412] | <0.001 |
Abbreviations: POAF, Post-operative atrial fibrillation
Patients with pre-existing atrial fibrillation, as determined by present-on-admission coding, were excluded from this analysis
Length of stay log transformed in adjusted and unadjusted models, length of stay is in days
top 5th percentile of cost removed to reduce skewness, cost is in dollars